Manchester Capital Management LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 170 filers reported holding HAEMONETICS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Manchester Capital Management LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2020$0
-100.0%
3
-99.8%
0.00%
-100.0%
Q4 2015$42,0000.0%1,3000.0%0.01%
-14.3%
Q3 2015$42,000
-30.0%
1,300
-18.8%
0.01%0.0%
Q4 2014$60,000
-46.4%
1,600
-50.0%
0.01%
-53.3%
Q3 2014$112,000
-0.9%
3,2000.0%0.02%0.0%
Q2 2014$113,000
-67.7%
3,200
-61.5%
0.02%
-72.7%
Q4 2013$350,000
+9.7%
8,310
+3.7%
0.06%0.0%
Q3 2013$319,000
+490.7%
8,010
+516.2%
0.06%
+450.0%
Q2 2013$54,0001,3000.01%
Other shareholders
HAEMONETICS CORP shareholders Q3 2015
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders